Pink Sheet

Coronavirus Supply Chain Threats Demand Coordinated Industry Response

By Bowman Cox 27 Nov 2020

Just as they did during the heparin crisis a decade ago, pharmaceutical companies must coordinate on coronavirus, Rx-360 CEO says.

Topic Manufacturing Vaccines Coronavirus

Scrip

Coronavirus Update: Moderna And Pfizer Respond To Vaccine Trial Transparency Demands

By Scrip Team 25 Sep 2020

Moderna led by releasing the trial protocol for its COVID-19 vaccine study, followed by Pfizer, as industry faces demands for transparency.

Topic Coronavirus Manufacturing Clinical Trials

Pink Sheet

Global Supply Chain Security Meets US Presidential Politics

By Michael McCaughan 21 Sep 2020

Joe Biden’s presidential campaign now has a plan to address supply chains and encourage US-based manufacturing of prescription drugs. That affirms the unlikely national prominence of the issue – and reduces the chances of meaningful legislation this year.

Topic US Election 2020 Manufacturing

Pink Sheet

US Researchers Working Toward Universal Coronavirus Vaccine

By Sue Sutter 18 Feb 2020

The SARS-CoV-2 outbreak has the federal government working not only on a vaccine candidate specifically targeted at the novel coronavirus but also thinking more broadly about ways to head off future potential pandemics with emerging pathogens.

Topic Coronavirus Vaccines Manufacturing

In Vivo

Outlook 2020 Report

18 Dec 2019

Tap Outlook 2020’s essential coverage of medtech, R&D, clinical trials and regulation, manufacturing, and more with your extract from our most powerful report.

Topic Outlook Medtech M A Manufacturing Market Intelligence Regulation Legislation Leadership